The 30-stock Dow lost 44.14 points, or 0.10%, and ended at 42,171.66. The S&P 500 slipped 0.03% to close at 5,980.87, and the ...

Factory Mutual Insurance Co. dramatically upped its stake in Regeneron Pharmaceuticals by 210.3%, acquiring an additional ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has ...

Regeneron Pharmaceuticals just got a haircut from Wall Street, with JPMorgan Chase & Co. lowering its price target from $950 ...

Dollar General might raise prices because of tariffs but it's the last resort, CEO Todd Vasos told investors on an earnings call. The chain is attracting even more lower-income shoppers than usual, ...

Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while maintaining an Overweight rating on the stock. The revision follows what the ...

BMO Capital lowered the firm’s price target on Regeneron (REGN) to $600 from $800 and keeps an Outperform rating on the shares.The firm is updating its model following “disappointing ...

Similar price hikes have been noted at Target as well. For example, a Jurassic World T. Rex toy at Walmart saw its price increase from $39.92 in late April to $55 in late May, a nearly 38% increase.

On Monday, Bernstein SocGen Group lowered the price target for Regeneron Pharma stock (NASDAQ: NASDAQ:REGN) to $750 from $896, while maintaining an Outperform rating. This adjustment follows Regeneron ...